Lanxess shares downgraded to underweight by JPMorgan

Published 11/10/2024, 11:16
Lanxess shares downgraded to underweight by JPMorgan

On Friday, JPMorgan issued a downgrade for Lanxess AG (ETR:LXSG) (LXS:GR) (OTC: LNXSF), shifting the rating from Neutral to Underweight and maintaining a price target of €26.00. The firm highlighted that Lanxess' share price has surpassed the December 2025 target, prompting the rating change.

The downgrade comes amid a challenging macroeconomic environment, with uncertainties around the timing and impact of demand changes due to China's stimulus measures and interest rate cuts in various regions. The firm notes that while some investors expect Lanxess' earnings to rebound strongly in a macro recovery, the current economic outlook does not support a bullish stance.

In response to the tough macro backdrop, Lanxess has implemented several strategies over the past two years. These include cost-cutting measures, reductions in capital expenditures and working capital, as well as asset sales, all aimed at navigating the difficult economic conditions and improving the company's balance sheet.

JPMorgan's stance reflects skepticism regarding the potential for a near-term demand inflection for Lanxess, despite the company's actions to mitigate the effects of the challenging macro environment. The firm's maintained price target of €26.00 is based on the unchanged outlook for December 2025.

In other recent news, Lanxess AG has been the focus of significant analyst attention. Morgan Stanley has upgraded Lanxess stock from Underweight to Overweight, raising the price target to EUR 37.00. This change reflects the bank's confidence in Lanxess' strategic focus on disposal and free cash flow, projected to lower the company's net debt. Morgan Stanley also suggests that the market undervalues Lanxess' Envalior unit, which could generate around EUR 450 million in EBITDA and add value to Lanxess' shares.

Deutsche Bank has also updated its financial model for Lanxess, resulting in a price target increase from €27.00 to €28.00. This adjustment is driven by an optimistic outlook for Lanxess' 2024 EBITDA, now forecasted to be €612 million, a 9% increase from previous estimates. The bank's revised model anticipates significant cost savings and the elimination of previously estimated inventory reduction.

The management of Lanxess AG has projected that the third quarter of 2024's EBITDA will be close to or higher than the second quarter's reported EBITDA of €181 million. These recent developments provide a comprehensive view of Lanxess AG's financial outlook, as interpreted by analysts from Morgan Stanley and Deutsche Bank.

InvestingPro Insights

Adding to JPMorgan's analysis, recent InvestingPro data provides a nuanced view of Lanxess AG's financial position. Despite the challenging macroeconomic environment highlighted in the article, InvestingPro Tips suggest that Lanxess's net income is expected to grow this year, and analysts predict the company will return to profitability. This optimism contrasts with the company's current unprofitable status over the last twelve months, as indicated by its negative P/E ratio of -7.13.

The stock's recent performance aligns with JPMorgan's observation of the share price surpassing targets, with InvestingPro data showing strong returns of 11.14% over the last month and 15.9% over the last three months. The stock is currently trading near its 52-week high, at 98.05% of that peak.

Interestingly, despite the downgrade, Lanxess maintains a high shareholder yield and has a track record of 18 consecutive years of dividend payments, which may appeal to income-focused investors. The company's price-to-book ratio of 0.55 suggests it might be undervalued relative to its assets, potentially offering a margin of safety for long-term investors.

For those seeking a deeper analysis, InvestingPro offers 11 additional tips for Lanxess AG, providing a more comprehensive view of the company's prospects in light of the current market conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.